Patents by Inventor Suhail Nurbhai

Suhail Nurbhai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS USEFUL FOR TREATING GASTROESOPHAGEAL REFLUX DISEASE
    Publication number: 20110275667
    Abstract: The present invention relates to a method of treating GERD in a human subject in need of treatment. The method comprises orally administering to said subject an effective amount of a thieno[3,2-b]pyridine compound of Structural Formula I or a pharmaceutically acceptable salt or N-oxide derivative thereof, wherein the effective amount is from about one to about three daily doses of the compound and the dose is from about 0.2 mg to about 0.5 mg.
    Type: Application
    Filed: July 19, 2011
    Publication date: November 10, 2011
    Applicant: EDUSA Pharmaceuticals, Inc.
    Inventors: Suhail Nurbhai, Steven B. Landau
  • COMPOSITIONS USEFUL FOR TREATING IRRITABLE BOWEL SYNDROME
    Publication number: 20110269792
    Abstract: The present invention relates to a method of treating irritable bowel syndrome with constipation (IBS-c) or irritable bowel syndrome with alternating constipation and diarrhea (IBS-a) in a subject in need of treatment. The method comprises administering to said subject a therapeutically effective amount of a thieno[3,2-b]pyridine compound of Structural Formula I or a pharmaceutically acceptable salt or N-oxide derivative thereof.
    Type: Application
    Filed: July 11, 2011
    Publication date: November 3, 2011
    Applicant: EDUSA Pharmaceuticals, Inc.
    Inventors: Steven B. Landau, Suhail Nurbhai
  • COMPOSITIONS USEFUL FOR TREATING GASTROESOPHAGEAL REFLUX DISEASE
    Publication number: 20100247584
    Abstract: The present invention relates to a method of treating GERD in a human subject in need of treatment. The method comprises orally administering to said subject an effective amount of a thieno[3,2-b]pyridine compound of Structural Formula I or a pharmaceutically acceptable salt or N-oxide derivative thereof, wherein the effective amount is from about one to about three daily doses of the compound and the dose is from about 0.2 mg to about 0.5 mg.
    Type: Application
    Filed: April 1, 2010
    Publication date: September 30, 2010
    Applicant: EDUSA Pharmaceuticals, Inc.
    Inventors: Suhail Nurbhai, Steven B. Landau
  • Compositions Useful For Treating Irritable Bowel Syndrome
    Publication number: 20100152231
    Abstract: The present invention relates to a method of treating irritable bowel syndrome with constipation (IBS-c) or irritable bowel syndrome with alternating constipation and diarrhea (IBS-a) in a subject in need of treatment. The method comprises administering to said subject a therapeutically effective amount of a thieno[3,2-b]pyridine compound of Structural Formula I or a pharmaceutically acceptable salt or N-oxide derivative thereof.
    Type: Application
    Filed: December 10, 2009
    Publication date: June 17, 2010
    Inventors: Steven B. Landau, Suhail Nurbhai
  • Compositions useful for treating gastroesophageal reflux disease
    Publication number: 20090131471
    Abstract: The present invention relates to a method of treating GERD in a human subject in need of treatment. The method comprises orally administering to said subject an effective amount of a thieno[3,2-b]pyridine compound of Structural Formula I or a pharmaceutically acceptable salt or N-oxide derivative thereof, wherein the effective amount is from about one to about three daily doses of the compound and the dose is from about 0.2 mg to about 0.5 mg.
    Type: Application
    Filed: June 4, 2008
    Publication date: May 21, 2009
    Inventors: Suhail Nurbhai, Steven B. Landau
  • COMPOSITIONS USEFUL FOR TREATING IRRITABLE BOWEL SYNDROME
    Publication number: 20080269276
    Abstract: The present invention relates to a method of treating irritable bowel syndrome with constipation (IBS-c) or irritable bowel syndrome with alternating constipation and diarrhea (IBS-a) in a subject in need of treatment. The method comprises administering to said subject a therapeutically effective amount of a thieno[3,2-b]pyridine compound of Structural Formula I or a pharmaceutically acceptable salt or N-oxide derivative thereof.
    Type: Application
    Filed: February 8, 2008
    Publication date: October 30, 2008
    Applicant: Dynogen Pharmaceuticals, Inc.
    Inventors: Steven B. Landau, Suhail Nurbhai